Zobrazeno 1 - 10
of 30
pro vyhledávání: '"KARPATI, EGON"'
Publikováno v:
In Journal of Pharmacological and Toxicological Methods 2005 52(2):264-273
Autor:
Vas, Ádám *, a, Gulyás, Balázs b, c, Szabó, Zsolt a, Bönöczk, Péter a, Csiba, László d, Kiss, Béla a, Kárpáti, Egon a, Pánczél, Gyula e, Nagy, Zoltán e
Publikováno v:
In Journal of the Neurological Sciences 2002 203:259-262
Autor:
Bönöczk, Péter 1, Gulyás, Balázs 2, Adam-Vizi, Vera 3, Nemes, András 1, Kárpáti, Egon 1, Kiss, Béla 1, Kapás, Margit 1, Szántay, Csaba 4, Koncz, István 5, Zelles, Tibor 5, Vas, Adam 1, *
Publikováno v:
In Brain Research Bulletin 2000 53(3):245-254
Autor:
Bela Kiss, Gyula Panczel, Ádám Vas, Balázs Gulyás, Zoltán Nagy, Zsolt Szabó, Péter Bönöczk, László Csiba, Karpati Egon
Publikováno v:
Journal of the Neurological Sciences. :259-262
Vinpocetine (Cavinton, Gedeon Richter, Budapest) is widely used as a neuroprotective drug in the prevention and treatment of cerebrovascular diseases. Vinpocetine is a potent inhibitor of the voltage-dependent Na(+) channels and a selective inhibitor
Autor:
Lars Farde, Christer Halldin, Judit Sovago, Karpati Egon, Ádám Vas, Zsolt Cselényi, Balázs Gulyás, Bela Kiss, Johan Sandell
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 29:1031-1038
Direct information on the distribution of a drug requires measurements in various tissues. Such data have until now been obtained in animals, or have indirectly been calculated from plasma measurements in humans using mathematical models. Here we sug
Autor:
Péter Bönöczk, Balázs Gulyás, Vera Adam-Vizi, Bela Kiss, Ádám Vas, Tibor Zelles, Csaba Szántay, István Koncz, Andras Nemes, Margit Kapás, Karpati Egon
Publikováno v:
Brain Research Bulletin. 53:245-254
Vinpocetine (ethyl apovincaminate) discovered during the late 1960s has successfully been used in the treatment of central nervous system disorders of cerebrovascular origin for decades. The increase in the regional cerebral blood flow in response to
Publikováno v:
Brain Research Bulletin. 45:475-488
RGH-2716 is a novel 1-oxa-3,8-diazaspiro[4.5] decan 2-one, which was published to have potent inhibitory effect on neuronal Na and Ca movement and stimulatory action on nerve growth factor (NGF)-production, as well as to show significant antiamnesic
Autor:
Martin Kessel, Laszlo Czibula, Karpati Egon, Janos Kreidl, Zsolt Szombathelyi, Maria Farkas, Pál Sohár, Gyorgy Visky, Andras Nemes
Publikováno v:
ChemInform. 24
The synthesis of all the possible isomers of the eburnameninevincamine type alkaloids 1b, 2a, 3a and derivatives 4, 8, 9, 10 is described. Structures were determined by 1H- and 13C-NMR spectroscopy including special techniques such as DR, DEPT, DNOE,
Publikováno v:
Pharmacological research. 35(4)
The aim of this study was to investigate the effect of bisaramil—an antiarrhythmic drug under clinical trials—on free radical generation of isolated polymorph neutrophil granulocytes (PMN) and furthermore to compare its activity to that of well-k
Publikováno v:
Pharmacological research. 33(6)
The aim of this study was to determine whether bisaramil—an antiarrhythmic compound under clinical investigation—influences the reperfusion–induced arrhythmias and biochemical parameters characterizing occlusion-reperfusion-induced free-radical